Front-Line Tyrosine Kinase Inhibitors in Pediatric Chronic Myeloid Leukemia: A Study on Efficacy and Safety

SIMPLE SUMMARY: Tyrosine kinase inhibitors (TKIs) have significantly improved treatment outcomes in pediatric patients with chronic myeloid leukemia (CML). However, there is insufficient evidence suggesting the superiority of one TKI over another in terms of treatment response and long-term adverse...

Descripción completa

Detalles Bibliográficos
Autores principales: Yoo, Jae Won, Jo, Suejung, Ahn, Moon Bae, Kim, Seongkoo, Lee, Jae Wook, Kim, Myungshin, Cho, Bin, Chung, Nack-Gyun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10416896/
https://www.ncbi.nlm.nih.gov/pubmed/37568679
http://dx.doi.org/10.3390/cancers15153862

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10416896/
https://www.ncbi.nlm.nih.gov/pubmed/37568679
http://dx.doi.org/10.3390/cancers15153862

Ejemplares similares